October 2026 brings wider over-the-counter access to a prescription-strength acne gel, strong 52-week results for an oral acne drug, and FDA clearance for U.S. testing of that drug. Routine means the daily steps of cleansing, treating, moisturizing, and sun protection that support acne care.
Differin Epiduo Gel now offers adapalene 0.1% plus benzoyl peroxide 2.5% without a prescription for ages 12 and older. Denifanstat, an oral drug for moderate-to-severe acne, showed sustained improvement through 52 weeks and earned FDA clearance for a U.S. Phase 3 trial.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Register through Globenewswire’s official page — Use this page to review requirements and register directly.
- Apply through Financialcontent’s official page — Use this page to review requirements and apply directly.
Table of Contents
- What can you buy without a prescription now?
- How strong is the new year-long drug data?
- What trials could change future options?
- How should your daily routine look now?
- Should you check your benzoyl peroxide products?
- What can you buy without a prescription now?
- How strong is the new year-long drug data?
- What trials could change future options?
- How should your daily routine look now?
- Should you check your benzoyl peroxide products?
What can you buy without a prescription now?
Galderma said in the Galderma approval announcement that Differin Epiduo Gel received FDA approval for over-the-counter use in ages 12 and older. Adapalene is a topical retinoid that helps keep pores clear. Benzoyl peroxide fights acne-causing bacteria. This switch matters for routine planning.
A fixed-dose combination joins retinoids and benzoyl peroxide among treatments with strong backing in current dermatology guidelines. It gives teens and adults a prescription-strength option without a clinic visit. Check age, ingredients, and use directions before buying. Start once daily as directed and add a gentle moisturizer if dryness appears. Stop and seek care for severe irritation, swelling, or signs of allergy.
How strong is the new year-long drug data?
Dermatology Times reported in the 52-week results summary that oral denifanstat reached 56.7% treatment success and 71.8% mean total lesion reduction after up to 52 weeks. The results came from a Phase 3 open-label extension in moderate-to-severe acne. Longer use linked with greater cumulative improvement. Sagimet Biosciences said in the full trial results that the 52-week extension enrolled 240 prior trial patients in China.
That group included 124 prior-placebo patients who reached similar success after crossing to denifanstat. The pattern supports steady gains with continued treatment. Denifanstat remains investigational and is not available by prescription. The data apply to moderate-to-severe acne under trial care. People with mild acne or well-controlled symptoms are outside this evidence.
What trials could change future options?
Sagimet Biosciences said in the FDA clearance update that FDA issued a Study May Proceed letter for a U.S. Phase 3 AURORA trial. The planned trial covers adolescent and adult patients with moderate-to-severe acne. U.S. testing follows the China extension results.
A separate early vaccine program is also active. Sanofi Pasteur lists a first-in-human Phase I/II mRNA acne vaccine trial in adults 18 to 45 with moderate-to-severe acne. The design tests four doses versus placebo for safety, efficacy, and immune response through 2027. Neither option changes home care today. Trial drugs require enrollment, monitoring, and medical supervision. Readers interested in trials should discuss eligibility, site location, and risks with a dermatologist.
How should your daily routine look now?
The American Academy of Dermatology says clearer skin requires both acne-friendly skin care and the right treatment for each blemish type. Acne products often cause dryness. Pair treatment with a gentle cleanser, moisturizer, and daily sun protection.
The Academy guidelines give strong support to topical benzoyl peroxide, retinoids, antibiotics, fixed-dose combinations, and oral isotretinoin for severe acne. Newer options such as clascoterone and sarecycline have only conditional support, partly over high cost and access limits. Match product strength to acne severity and tolerance. Use a simple routine you can follow every day:.
- cleanse gently morning and night without scrubbing
- apply acne treatment thinly to affected areas
- moisturize to reduce dryness and flaking
- wear broad-spectrum sunscreen each morning
Should you check your benzoyl peroxide products?
FDA testing of 95 benzoyl peroxide acne products found six lots with elevated benzene. The finding prompted voluntary retail recalls including La Roche-Posay, Proactiv, SLMD, and Walgreens lots. FDA described cancer risk from this contamination as very low.
Do not panic and do not stockpile old tubes. Check lot numbers on packages against recall notices. Throw away or return affected lots and replace with a fresh product stored in a cool place.
What can you buy without a prescription now?
Galderma said in the Galderma approval announcement that Differin Epiduo Gel received FDA approval for over-the-counter use in ages 12 and older. Adapalene is a topical retinoid that helps keep pores clear. Benzoyl peroxide fights acne-causing bacteria. This switch matters for routine planning.
A fixed-dose combination joins retinoids and benzoyl peroxide among treatments with strong backing in current dermatology guidelines. It gives teens and adults a prescription-strength option without a clinic visit. Check age, ingredients, and use directions before buying. Start once daily as directed and add a gentle moisturizer if dryness appears. Stop and seek care for severe irritation, swelling, or signs of allergy.
How strong is the new year-long drug data?
Dermatology Times reported in the 52-week results summary that oral denifanstat reached 56.7% treatment success and 71.8% mean total lesion reduction after up to 52 weeks. The results came from a Phase 3 open-label extension in moderate-to-severe acne. Longer use linked with greater cumulative improvement. Sagimet Biosciences said in the full trial results that the 52-week extension enrolled 240 prior trial patients in China.
That group included 124 prior-placebo patients who reached similar success after crossing to denifanstat. The pattern supports steady gains with continued treatment. Denifanstat remains investigational and is not available by prescription. The data apply to moderate-to-severe acne under trial care. People with mild acne or well-controlled symptoms are outside this evidence.
What trials could change future options?
Sagimet Biosciences said in the FDA clearance update that FDA issued a Study May Proceed letter for a U.S. Phase 3 AURORA trial. The planned trial covers adolescent and adult patients with moderate-to-severe acne. U.S. testing follows the China extension results.
A separate early vaccine program is also active. Sanofi Pasteur lists a first-in-human Phase I/II mRNA acne vaccine trial in adults 18 to 45 with moderate-to-severe acne. The design tests four doses versus placebo for safety, efficacy, and immune response through 2027. Neither option changes home care today. Trial drugs require enrollment, monitoring, and medical supervision. Readers interested in trials should discuss eligibility, site location, and risks with a dermatologist.
How should your daily routine look now?
The American Academy of Dermatology says clearer skin requires both acne-friendly skin care and the right treatment for each blemish type. Acne products often cause dryness. Pair treatment with a gentle cleanser, moisturizer, and daily sun protection.
The Academy guidelines give strong support to topical benzoyl peroxide, retinoids, antibiotics, fixed-dose combinations, and oral isotretinoin for severe acne. Newer options such as clascoterone and sarecycline have only conditional support, partly over high cost and access limits. Match product strength to acne severity and tolerance. Use a simple routine you can follow every day:.
- cleanse gently morning and night without scrubbing
- apply acne treatment thinly to affected areas
- moisturize to reduce dryness and flaking
- wear broad-spectrum sunscreen each morning
Should you check your benzoyl peroxide products?
FDA testing of 95 benzoyl peroxide acne products found six lots with elevated benzene. The finding prompted voluntary retail recalls including La Roche-Posay, Proactiv, SLMD, and Walgreens lots. FDA described cancer risk from this contamination as very low.
Do not panic and do not stockpile old tubes. Check lot numbers on packages against recall notices. Throw away or return affected lots and replace with a fresh product stored in a cool place.